Cohort Study

Download as ppt, pdf, or txt
Download as ppt, pdf, or txt
You are on page 1of 28

COHORT STUDY

Dr Debadatta Chakrabarty
Epidemiology
Defined by John M. Last in 1988
 “Study of Distribution and Determinants of
health related state or event in a specified
population and the application of this
study to the control of health problem”.
 We measure –
 Disease frequency
 Diseases distribution
 Determinants of disease.
TYPES OF EPIDEMIOLOGICAL STUDIES
1. OBSERVATIONAL STUDIES
A. DESCRIPTIVE STUDY
DESCRIBE DIESEASE BY
TIME
PLACE
PERSON
B. ANALYTICAL STUDIES
ECOLOGICAL STUDY
CROSS SECTIONAL STUDY
CASE-CONTROL STUDY
COHORT STUDY
2. EXPEREMENTAL STUDIES
RANDOMIZED CONTROLLED TRIAL (RCT)
FIELD TRIAL
COMMUNITY TRIAL
Descriptive Epidemiology
 Describe the disease by
 Time
 Place
 Person
•Cohort study is undertaken to support the
existence of association between suspected
cause and disease
 A major limitation of cross-sectional surveys and
case-control studies is difficulty in determining if
exposure or risk factor preceded the disease or
outcome.
 Cohort Study:

Key Point:

 Presence or absence of risk factor is


determined before outcome occurs.
WHAT IS COHORT
 Ancient Roman
military unit, A band
of warriors.
 Persons banded
together.
 Group of persons with
a common statistical
characteristic. [Latin]
 E.g. age, birth date,
Cohort studies
 longitudinal
 Prospective studies
 Forward looking study
 Incidence study

 starts with people free of disease


 assesses exposure at “baseline”
 assesses disease status at “follow-up”
INDICATION OF A COHORT STUDY
 When there is good evidence of exposure
and disease.
 When exposure is rare but incidence of
disease is higher among exposed
 When follow-up is easy, cohort is stable
 When ample funds are available
Frame work of Cohort studies
Disease Status
Total Yes No

Study
Exposure
Yes a+b a b cohort

Status
No Comparison
c+d c d cohort

N a+c b+d
General consideration while selection
of cohorts
 Both the cohorts are free of the disease.
 Both the groups should equally susceptible
to disease
 Both the groups should be comparable
 Diagnostic and eligibility criteria for the
disease should be defined well in advance.
Elements of cohort study
 Selection of study subjects
 Obtaining data on exposure
 Selection of comparison group
 Follow up
 Analysis
Selection of study subjects
 General population
 Whole population in an area
 A representative sample
 Special group of population
 Select group
 occupation group / professional group (Dolls study )
 Exposure groups
 Person having exposure to some physical, chemical or
biological agent
 e.g. X-ray exposure to radiologists
Obtaining data on exposure
 Personal interviews / mailed questionnaire
 Reviews of records
 Dose of drug, radiation, type of surgery etc
 Medical examination or special test
 Blood pressure, serum cholesterol
 Environmental survey

 By obtaining the data of exposure we can


classify cohorts as
 Exposed and non exposed and
 By degree exposure we can sub classify cohorts
Selection of comparison group
 Internal comparison
 Only one cohort involved in study
 Sub classified and internal comparison done
 External comparison
 More than one cohort in the study for the purpose of
comparison
 e.g. Cohort of radiologist compared with
ophthalmologists
 Comparison with general population rates
 If no comparison group is available we can compare
the rates of study cohort with general population.
 Cancer rate of uranium miners with cancer in general
population
Follow-up
 To obtain data about outcome to be determined
(morbidity or death)
 Mailed questionnaire, telephone calls, personal
interviews
 Periodic medical examination
 Reviewing records
 Surveillance of death records
 Follow up is the most critical part of the study
 Some loss to follow up is inevitable due to death
change of address, migration, change of
occupation.
 Loss to follow-up is one of the draw-back of the
cohort study.
ANALYSIS

 Calculation of incidence rates among


exposed and non exposed groups

 Estimation of risk
Incidence rates of outcome
Disease Status
Yes No Total

Study
Exposure
Yes a b a+b cohort

Status
No Comparison
c d c+d cohort

a+c b+d N
Incidence rate
 Incidence among exposed =
a
a+b
 Incidence among non-exposed =
c
c+d
Estimation of risk
Relative Risk
incidence of disease among exposed
RR = ______________________________
Incidence of disease among non-exposed
a/a+b
= _________
c/c+d
Estimation of Risk
Attributable Risk
Incidence of disease among exposed –
incidence of disease among non exposed
AR = _______________________________
Incidence of disease among exposed
a/a+b – c/c+d
AR = _______________
a/a+b
Smoking Lung cancer Total

YES NO

YES 70 6930 7000

NO 3 2997 3000

73 9927 10000

Find out RR and AR for above data


 Incidence of lung cancer among smokers
70/7000 = 10 per 1000
 Incidence of lung cancer among non-smokers
3/3000 = 1 per thousand
RR = 10 / 1 = 10
(lung cancer is 10 times more common among
smokers than non smokers)
AR = 10 – 1 / 10 X 100
= 90 %
(90% of the cases of lung cancer among
smokers are attributed to their habit of smoking)
Types of Cohort Study
 Prospective cohort study
 Retrospective (historical) cohort study
 Combination of Retrospective and
Prospective cohort study.
Cohort studies
Strengths
Weaknesses
 We can find out
incidence rate and  losses to follow-up
risk  often requires large
 More than one sample
disease related to  ineffective for rare
single exposure diseases
 can establish cause -  long time to complete
effect
 good when exposure
 expensive
is rare  Ethical issues
 minimizes selection
and information bias
THANK YOU

You might also like